These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 11350271
1. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Metry G, Hall C, Wikström B, Källskog V, Hansell P, Danielson B. Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271 [Abstract] [Full Text] [Related]
2. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Franz M, Woloszczuk W, Hörl WH. Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584 [Abstract] [Full Text] [Related]
3. Utility of the inferior vena cava diameter as a marker of dry weight in nonoliguric hemodialyzed patients. Yanagiba S, Ando Y, Kusano E, Asano Y. ASAIO J; 2001 Jul; 47(5):528-32. PubMed ID: 11575831 [Abstract] [Full Text] [Related]
4. Relationship between filtration coefficients of microvasculature and levels of atrial natriuretic peptide or echocardiographic measurements. Yashiro M, Watanabe H, Tomita M, Yamadori N, Muso E. Blood Purif; 2005 Jul; 23(6):431-9. PubMed ID: 16155375 [Abstract] [Full Text] [Related]
5. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure. Lettgen B, Bald M, Valleé H, Bonzel KE, Rascher W. Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187 [Abstract] [Full Text] [Related]
6. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Am J Nephrol; 2001 Jan; 21(2):112-9. PubMed ID: 11359018 [Abstract] [Full Text] [Related]
7. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD. Plum J, Ziyaie M, Kemmer FW, Passlick-Deetjen J, Grabensee B. Adv Perit Dial; 1990 Jan; 6():211-9. PubMed ID: 1982811 [Abstract] [Full Text] [Related]
8. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. Clerico A, Caprioli R, Del Ry S, Giannessi D. J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728 [Abstract] [Full Text] [Related]
17. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses. van der Vekens N, Decloedt A, de Clercq D, Ven S, Sys S, van Loon G. Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480 [Abstract] [Full Text] [Related]
18. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Haug C, Metzele A, Steffgen J, Grünert A. Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909 [Abstract] [Full Text] [Related]